FDA Investigator Demitria J Argiropoulos
Demitria J Argiropoulos has inspections in 1 countries as of 20 Sep 2023. Demitria J Argiropoulos has collaborated with a combined 1681 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
22
Last Inspection Date:
20 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alice S Tsao,
Althea A Williams,
Amber D Brodas,
Anissa M Vargas,
Ann M Stewart,
Anna M Alexander,
Antonina Aydanian,
Bijoy Panicker,
Brandy N Lepage,
Charanjeet Jassal,
Charisse K Green,
Charles Jewell,
D Jenny Argiropoulos,
Demitria J Argiiropoulos,
Demitria J Argiropolous,
Demitria J Xiradakis,
Dennis E Guilfoyle, PhD,
Diane L Raccasi,
Dr. Barbara D Paul, PhD,
Dr. Robert C Horan, MD,
Felix Maldonado,
Frank Verni,
Freyja V Lynn,
Gam S Zamil,
Gregson A Joseph,
Helen B Ricalde,
Irina Gaberman,
Jacqueline Mdiaz Albertini,
Jacqueline S Warner,
James A Liubicich,
James C Maclaughlin,
Jane Chen,
Jennifer L Bridgewater,
Jogy George,
Joseph J Vannelli,
Joseph Milcetic,
Juliana M Badalucco,
Julie D Bringger,
Karen L Kosar,
Kevin A Gonzalez,
Kristina L Conroy,
Kwong P Lee,
Lata C Mathew, PhD,
Leena Thomas,
Lori P Peters,
Manhar R Patel,
Margaret E Sarles,
Maria Joselopez Barragan, PhD,
Marie Elena C Puleo,
Marjorie A Shapiro, PhD,
Marsha W Major,
Martha T Olone,
Mary Davis Lopez,
Mate Tolnay,
Matthew A Spataro,
Michael Levin,
Mihaly S Ligmond,
Milan S Blake,
Mindy M Chou,
Nancy T Waites,
Omotunde O Osunsanmi,
Parul M Patel,
Paul E Stein,
Paul Mouris,
Paula A Trost,
Perry T Nichols,
Philip F Istafanos, DMV, MS,
Prabhu P Raju,
Rachael O Oyewole,
Richard W Thornton,
Robert C Steyert,
Robert Jennings,
Robert W Jennings,
Ruben C Quintana,
Samina S Khan,
Samuel T Walker,
Sarah B Tanksley,
Satheesh Thomas,
Scott E Norris,
Shari L Kahn,
Simone E Pitts,
Sony Mathews,
Stella Yuen,
Steven M Weinman,
Susan F Laska, MS,
Susan M Jackson,
Syeda N Mahazabin,
Tanya R Syffrard,
Tara K Carmody,
Tej Poonai,
Tina S Roecklein,
Unnee Ranjan,
Vivin George,
Wayne E Seifert,
Yvins Dezan
Demitria J Argiropoulos's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more